Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Cure Today
17m
Opdivo with Abraxane May Expand Therapeutic Opportunities For MIBC
Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.
42m
Bristol-Myers trades in the green for seventh straight session
Bristol-Myers Squibb (BMY) stock shows potential for growth with recent FDA approval and strong oncology portfolio, but faces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US adds 254,000 jobs
Accused of sexual assault
Registration deadlines
US launches airstrikes
Antarctica turning green
Nevada politician guilty
Jan. 6 charges dismissal bid
Wreck of WWII ship found
To stay at rescue center
Murder case to be reviewed
Plastic-eating bacteria
Union skips endorsement
Water fluoridation research
Read seeks to delay lawsuit
Processing times drop
Tropical Storm Leslie forms
To stop linking to NZ news?
To weigh Mexico’s $10B suit
CDC flu vaccine report
CA dairy workers infected
3 pitching coaches fired
Debt plan blocked again
Free tax filing expansion
First mpox test approved
Senators urge DOJ action
To add Hyundai EVs
Mich. double voting incident
Related topics
Nivolumab
Food and Drug Administration
Bristol-Myers Squibb
Resectable NSCLC
Pembrolizumab
Feedback